Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.019 | 0.7 |